Follow
Immunotherapy
Immunotherapy: is a type of cancer treatment the helps the immune system to fight cancer. The immune system helps your body fight infections and other diseases. It uses substances made by the body or in a laboratory in order to improve or restore the body's immune system function.
What's Popular in Immunotherapy
-
FEB 10, 2026Microbiology
There are huge communities of gut bacteria living in and on our bodies, and they can have a profound effect on us. New r ...Written By: Carmen LeitchFEB 09, 2026Cancer
Research has suggested that cancer treatments administered early in the day are more effective than those administered l ...Written By: Katie KokolusFEB 05, 2026Immunology
Immunotherapy has transformed the field of medicine. In the context of cancer, immune cells become dysregulated and lose ...Written By: Brian G. MorrealeJAN 15, 2026Immunology
The concept of immunotherapy or boosting the body’s immune system to target tumors was first practically applied i ...Written By: Brian G. MorrealeJAN 15, 2026Immunology
The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year. Unfo ...Written By: Brian G. Morreale
FEB 10, 2026
Microbiology
There are huge communities of gut bacteria living in and on our bodies, and they can have a profound effect on us. New r
...
Written By:
Carmen Leitch
FEB 09, 2026
Cancer
Research has suggested that cancer treatments administered early in the day are more effective than those administered l
...
Written By:
Katie Kokolus
FEB 05, 2026
Immunology
Immunotherapy has transformed the field of medicine. In the context of cancer, immune cells become dysregulated and lose
...
Written By:
Brian G. Morreale
JAN 15, 2026
Immunology
The concept of immunotherapy or boosting the body’s immune system to target tumors was first practically applied i
...
Written By:
Brian G. Morreale
JAN 15, 2026
Immunology
The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year. Unfo
...
Written By:
Brian G. Morreale
JAN 08, 2026
Immunology
The gut microbiome has been shown to influence tumor growth and contribute to therapeutic resistance. Scientists have co
...
Written By:
Brian G. Morreale
JAN 01, 2026
Immunology
Allergies are becoming more prevalent in the US, affecting over 100 million individuals. Common allergies include eczema
...
Written By:
Brian G. Morreale
JAN 01, 2026
Immunology
Immune cells work to fight infection and other diseases. Different subsets work together to elicit a healthy immune resp
...
Written By:
Brian G. Morreale
DEC 18, 2025
Immunology
Immunotherapy has transformed healthcare and how physicians treat patients. Various forms of immunotherapy have been dev
...
Written By:
Brian G. Morreale
-
DEC 18, 2025 | 8:00 AM
Immunotherapy has transformed cancer treatment, but persistent challenges, such as T cell exhaustion, limited persistence, and variability in response, continue to impact therapeutic success...NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...OCT 22, 2025 | 12:00 PM
Engineered immune cell therapies offer the promise of more tailored interventions than traditional systemic checkpoint blockades, but so far remain ineffective across the majority of clinica...
OCT 17, 2025 | 8:00 AM
Hepatobiliary cancers, including hepatocellular carcinoma (HCC) and gallbladder cancer (GBC), are strongly linked to chronic inflammation. Recent research using the Olink PEA Technology sugg...
JUN 25, 2025 | 11:00 PM
Learn how blood-based multiomics reveals tumor-specific biomarkers in pediatric cancers, aiding personalized immunotherapy-without invasive biopsies....
DEC 18, 2025 | 8:00 AM
Immunotherapy has transformed cancer treatment, but persistent challenges, such as T cell exhaustion, limited persistence, and variability in response, continue to impact therapeutic success...
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...
OCT 22, 2025 | 12:00 PM
Engineered immune cell therapies offer the promise of more tailored interventions than traditional systemic checkpoint blockades, but so far remain ineffective across the majority of clinica...
OCT 17, 2025 | 8:00 AM
Hepatobiliary cancers, including hepatocellular carcinoma (HCC) and gallbladder cancer (GBC), are strongly linked to chronic inflammation. Recent research using the Olink PEA Technology sugg...
JUN 25, 2025 | 11:00 PM
Learn how blood-based multiomics reveals tumor-specific biomarkers in pediatric cancers, aiding personalized immunotherapy-without invasive biopsies....
JUN 10, 2025 | 8:00 AM
Bispecific antibodies (bsAbs) represent a versatile and increasingly important class of targeted therapeutics, designed to bind two distinct sites — either two different epitopes on th...
MAY 13, 2025 | 9:00 AM
Immune checkpoint blockade (ICB) targeting T cells has enhanced clinical outcomes in patients with renal and bladder cancers; however, response rates remain limited, particularly in cases of...
On Demand
C.E. CREDITS
Clinical effectiveness of immune therapies of solid tumors requires a) the induction or expansion of T cells able of recognizing multiple variants of cancer cells present in each cancer pati...
APR 23, 2025 | 1:00 AM
Finding the right predictive and prognostic biomarkers is essential for improving cancer treatment. In this 30 min webinar, we’ll explore how NGS proteomics, combined with genomics , p...
-
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Labroots is pleased to announce the 6 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 28th, 2027. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to announce our 15th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2027 held on May 12th, 2027! The Precision Medicine: G...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Labroots is pleased to announce the 6 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 28th, 2027. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to announce our 15th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2027 held on May 12th, 2027! The Precision Medicine: G...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
OCT 08, 2025
| 8:00 AM PDT
The 2025 “Scripting the Future Summit,” hosted by GenScript, is the premier virtual gathering for scientists, biotech innovators, and pharmaceutical leaders exploring the next wa...
OCT 01, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
SEP 10, 2025
| 6:30 AM PDT
Join us for Innovations in Cancer Research Solutions , a 10-part virtual event showcasing the latest technologies advancing cancer research. From optimizing cell culture systems to studying...
APR 30, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking resea...